Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.06
+0.07 (1.40%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Protara Therapeutics Employees
Protara Therapeutics had 46 employees as of December 31, 2025. The number of employees increased by 18 or 64.29% compared to the previous year.
Employees
46
Change (1Y)
18
Growth (1Y)
64.29%
Revenue / Employee
n/a
Profits / Employee
-$1,248,674
Market Cap
273.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 147 |
| Zentalis Pharmaceuticals | 106 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Compugen | 75 |
| Cybin | 50 |
| Eledon Pharmaceuticals | 33 |
| NovaBridge Biosciences | 30 |
TARA News
- 1 day ago - Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting - GlobeNewsWire
- 7 weeks ago - Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update - GlobeNewsWire
- 2 months ago - Protara Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Protara Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Protara Therapeutics Transcript: Study update - Transcripts
- 2 months ago - TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 2 months ago - Protara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire